ZyVersa to Showcase Breakthrough Kidney Disease Drug at JPM Healthcare Conference 2025
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
Credit: Ozgu Arslan/Getty Images An international study, led by researchers at the Massachusetts General Hospital, has found that a combination...
Relatives of a Cuban woman who suffered from kidney problems reported her death due to a lack of medical care...
The landscape of kidney disease is ever-changing. Globally, changes in lifestyle have led to a steady increase in obesity and...
Global Developer of Advanced Healthcare Solutions Receives Innovative Technology Designation for its Liver Transient Elastography Imaging Technology from VizientMAHWAH, N.J.,...
Dr. Stalin Dharmayan went right to work Nov. 1, his first day as surgical director of UPMC Hamot's kidney transplant...